Farther Finance Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.5K Sell
224
-146
-39% -$12.9K ﹤0.01% 4201
2026
Q2
$35.5K Sell
370
-492
-57% -$50.4K ﹤0.01% 3527
2026
Q1
$93.7K Sell
862
-37
-4% -$3.53K ﹤0.01% 2558
2025
Q4
$72.9K Buy
899
+77
+9% +$6.63K ﹤0.01% 2550
2025
Q3
$71.9K Buy
822
+27
+3% +$2.41K ﹤0.01% 2238
2025
Q2
$66K Buy
795
+12
+2% +$1K ﹤0.01% 1990
2025
Q1
$66.7K Sell
783
-202
-21% -$18.8K ﹤0.01% 1748
2024
Q4
$90.8K Sell
985
-4
-0.4% -$385 ﹤0.01% 1349
2024
Q3
$91.9K Buy
989
+3
+0.3% +$260 ﹤0.01% 1339
2024
Q2
$79.4K Buy
986
+985
+98,500% +$72.4K ﹤0.01% 1230
2024
Q1
$66 Hold
1
– – ﹤0.01% 3440
2023
Q4
$57 Buy
+1
New +$52 ﹤0.01% 3361

Other funds holding LMAT

Farther Finance Advisors's LMAT Position: Q3 2026 in Review

Farther Finance Advisors reduced its LeMaitre Vascular (LMAT) stake by 39% in Q3 2026, selling an estimated $12.9K and leaving 224 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

Farther Finance Advisors first reported a position in LMAT in Q4 2023 and has held it in 12 quarters since. The position peaked at $93.7K in Q1 2026. 7 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Farther Finance Advisors held 224 shares of LeMaitre Vascular worth $18.5K as of Q3 2026.
  • Farther Finance Advisors sold 146 LeMaitre Vascular shares in Q3 2026, an estimated $12.9K.
  • LeMaitre Vascular made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4201 holding.
  • Farther Finance Advisors first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's LeMaitre Vascular position peaked at $93.7K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.